Experience with an IL-1ß inhibitor (anakinra) in a patient with CINCA/NOMID syndrome
Auteurs principaux: | S O Salugina, E S Fedorov, N N Kuzmina |
---|---|
Format: | Article |
Langue: | Russian |
Publié: |
IMA-PRESS LLC
2012-09-01
|
Collection: | Современная ревматология |
Accès en ligne: | https://mrj.ima-press.net/mrj/article/view/434 |
Documents similaires
-
CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors
par: S. O. Salugina, et autres
Publié: (2024-04-01) -
EXPERIENCE IN APPLICATION OF CANAKINUMAB IN PATIENTS WITH CRYOPYRIN-ASSOCIATED SYNDROME (SYNDROME CINCA/NOMID)
par: T. V. Sleptsova, et autres
Publié: (2014-05-01) -
The interleukin 1 inhibitor canakinumab in the treatment of cryopyrin-associated periodic syndromes (CAPS): clinical experience
par: Svetlana Olegovna Salugina, et autres
Publié: (2014-12-01) -
Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
par: Roy, N, et autres
Publié: (2019) -
Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis
par: Sullender RT, et autres
Publié: (2024-09-01)